These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7738213)

  • 1. Inhibition of angiotensin-converting enzyme with libenzapril in normotensive males.
    Morgan JM; Piraino AJ; Saris SD; Graham CS; Hirschhorn WL; Kochak GM; Choi RL
    J Clin Pharmacol; 1994 Dec; 34(12):1177-82. PubMed ID: 7738213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase on the vasopressor response to exogenous angiotensin I and angiotensin II challenges in healthy volunteers.
    Rousso P; Buclin T; Nussberger J; Brunner-Ferber F; Brunner HR; Biollaz J
    J Cardiovasc Pharmacol; 1998 Mar; 31(3):408-17. PubMed ID: 9514186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Need for plasma angiotensin measurements to investigate converting-enzyme inhibition in humans.
    Nussberger J; Juillerat L; Perret F; Waeber B; Bellet M; Brunner J; Ménard J
    Am Heart J; 1989 Mar; 117(3):717-22. PubMed ID: 2537557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the angiotensin II antagonist UP269-6 with the angiotensin converting enzyme inhibitor enalapril in normotensive volunteers challenged with angiotensin I.
    Inglessis N; Nussberger J; Hagmann M; Hiesse-Provost O; Insuasty J; Reid J; Ménard J; Brunner HR
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):986-93. PubMed ID: 7564346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ACE inhibition on pressor, renal vascular, and adrenal responses to infusion of angiotensin I in normal subjects eating a low-salt diet.
    Hollenberg NK; Fisher ND; Price DA; Williams GH
    Am J Hypertens; 2000 May; 13(5 Pt 1):498-503. PubMed ID: 10826400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating angiotensin II levels under repeated administration of lisinopril in normal subjects.
    Kawamura M; Imanashi M; Matsushima Y; Ito K; Hiramori K
    Clin Exp Pharmacol Physiol; 1992 Aug; 19(8):547-53. PubMed ID: 1326422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with perindopril in normal volunteers.
    Waeber B; Nussberger J; Perret L; Santoni JP; Brunner HR
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():35-41. PubMed ID: 2549899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of angiotensin I converting enzyme inhibition by SQ20,881 (less than Glu-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro) in vivo. Further evidence for extrapulmonary conversion.
    Oparil S; Koerner T; O'Donoghue JK
    Hypertension; 1979; 1(1):13-22. PubMed ID: 232489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats.
    Gardiner SM; Kemp PA; Brunner-Ferber F; Bennett T
    Br J Pharmacol; 1997 Dec; 122(8):1687-93. PubMed ID: 9422815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of different clinical and biochemical correlates to assess angiotensin converting enzyme inhibition.
    Delacrétaz E; Nussberger J; Püchler K; Wood AJ; Robinson PR; Waeber B; Brunner HR
    J Cardiovasc Pharmacol; 1994 Sep; 24(3):479-85. PubMed ID: 7528305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of the blood pressure response to exogenous angiotensin I after oral administration of benazepril to healthy adult horses.
    Afonso T; Giguère S; Rapoport G; Brown SA; Coleman AE
    Equine Vet J; 2017 May; 49(3):358-362. PubMed ID: 27224673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers.
    Rousso P; Buclin T; Nussberger J; Décosterd LA; La Roche SD; Brunner-Ferber F; Brunner HR; Biollaz J
    J Hypertens; 1999 Mar; 17(3):427-37. PubMed ID: 10100082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated plasma aldosterone levels despite complete inhibition of the vascular angiotensin-converting enzyme in chronic heart failure.
    Jorde UP; Vittorio T; Katz SD; Colombo PC; Latif F; Le Jemtel TH
    Circulation; 2002 Aug; 106(9):1055-7. PubMed ID: 12196328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of splanchnic and peripheral vascular tissues to the disposal of angiotensin-II and to regional conversion rates of angiotensin-I: a pilot study in humans.
    Gasic S; Kleinbloesem CH; Heinz G; Waldhäusl W
    J Cardiovasc Pharmacol; 1991 Apr; 17(4):615-20. PubMed ID: 1711629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gradual reactivation over time of vascular tissue angiotensin I to angiotensin II conversion during chronic lisinopril therapy in chronic heart failure.
    Farquharson CA; Struthers AD
    J Am Coll Cardiol; 2002 Mar; 39(5):767-75. PubMed ID: 11869839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic dependent disposition of the angiotensin converting enzyme inhibitor, libenzapril.
    Kochak GM; Choi RL; deSilva JK; Reydel-Bax P
    J Clin Pharmacol; 1990 Feb; 30(2):138-43. PubMed ID: 2312764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Converting-enzyme inhibition buffers the counter-regulatory response to acute administration of nicardipine.
    Bellet M; Sassano P; Guyenne T; Corvol P; Menard J
    Br J Clin Pharmacol; 1987 Oct; 24(4):465-72. PubMed ID: 3689627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gradual reactivation of vascular angiotensin I to angiotensin II conversion during chronic ACE inhibitor therapy in patients with diabetes mellitus.
    Sharman DC; Morris AD; Struthers AD
    Diabetologia; 2007 Oct; 50(10):2061-6. PubMed ID: 17676311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of action and short-term hormonal responses to enalapril (MK 421) in normal subjects.
    Given BD; Taylor T; Hollenberg NK; Williams GH
    J Cardiovasc Pharmacol; 1984; 6(3):436-41. PubMed ID: 6202969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.